Home > Analytics > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 524412     NSE : AAREYDRUGS    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : NA
Dec 13,2024
Price(EOD): ₹ 59.78
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 169.78 Cr
Value of ₹ 1 Lac invested in AAREY DRUGS & PHARMACEUTICALS
on Dec 16,2019 (price: ₹ 17.50)

₹ 1 L

₹ 3.42 L

1W : -4.2% 1M : -2.9% 1Y : 40.7%
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
AAREY DRUGS & PHARMACEUTICALS -4.2% -2.9% 40.7%
SUN PHARMACEUTICAL INDUSTRIES 0.4% 0.8% 45.4%
CIPLA -1.5% -5.1% 20.3%
DR REDDYS LABORATORIES -0.7% -1.3% 13.8%
ZYDUS LIFESCIENCES -0.5% 3% 54.1%
DIVIS LABORATORIES -1.4% 1.2% 62%
MANKIND PHARMA 0% 0.5% 38.1%
TORRENT PHARMACEUTICALS 0.4% 6.3% 60.1%
LUPIN -1.5% -0.6% 72.3%

FUNDAMENTAL ANALYSIS OF AAREY DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Sep2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF AAREY DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Dec 13,2024 ]

Ratio Standalone
P/E
P/B
P/S
24.59
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 6.89 Cr
[Latest Qtr - Sep2024 - Standalone Results ]

1.3
P/B Calculated based on Book Value of Rs 130.31 Cr
[Latest Year - Mar2024 - Standalone Results ]

0.33
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 8% undervalued companies ! Discover More →

FAIR VALUE OF AAREY DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
593%
157%
96%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AAREY DRUGS & PHARMACEUTICALS



AAREY DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AAREY DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.24
0.33
0.13
0.23
-
-
-
-
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AAREY DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AAREY DRUGS & PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-17.15%
216.21%
31.28%
28.92%
81.81%
101.68%
73.56%
103.57%
QtrlyTrend
6
Latest Qtr: Sep2024
Quarterly Result Analysis →


AAREY DRUGS & PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about AAREY DRUGS & PHARMACEUTICALS


Is AAREY DRUGS & PHARMACEUTICALS good for long term investment?

As on Dec 13,2024, the Fundamentals of AAREY DRUGS & PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of AAREY DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AAREY DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Dec 13,2024, AAREY DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS ?

As on Dec 13,2024, the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS is Rs. 23.28 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 8.63
Fair Value [Median EV / Sales Model] : Rs. 23.28
Fair Value [Median Price / Sales Model] : Rs. 30.48
Estimated Median Fair Value of AAREY DRUGS & PHARMACEUTICALS : Rs. 23.28

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AAREY DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Dec 13,2024, AAREY DRUGS & PHARMACEUTICALS is trading at a Premium of 157% based on the estimates of Median Intrinsic Value!